Related Experiment Video
Updated: Jun 9, 2025

11:53
Substrate Generation for Endonucleases of CRISPR/Cas Systems
Published on: September 8, 2012
27.3K
Structural variation of types IV-A1- and IV-A3-mediated CRISPR interference
R Čepaitė1, N Klein2, A Mikšys1,3
1LSC-EMBL Partnership Institute for Genome Editing Technologies, Life Sciences Center, Vilnius University, Vilnius, Lithuania.
Nature Communications
|October 29, 2024
Summary
Type IV-A CRISPR-Cas systems use a unique DNA-interference pathway independent of nucleases. Structural studies reveal how these systems bind DNA targets and recruit effector helicases for gene regulation.
Area of Science:
- Molecular Biology
- Microbiology
- Structural Biology
Background:
- CRISPR-Cas systems are known for sequence-specific DNA targeting and degradation.
- Type IV-A CRISPR-Cas systems represent a distinct class, utilizing a nuclease-independent mechanism for gene expression suppression.
- This pathway is employed in gene regulation and plasmid competition.
Purpose of the Study:
- To elucidate the mechanism of DNA interference by type IV-A CRISPR-Cas effector complexes.
- To determine the structural basis for target DNA recognition and R-loop formation.
- To understand the interaction with the DinG effector helicase.
Main Methods:
- Cryo-electron microscopy (cryo-EM) was used to determine the structures of type IV-A1 and IV-A3 complexes.
- Structures were obtained for complexes bound to cognate DNA targets, with and without the DinG helicase.
- Analysis focused on DNA interaction interfaces and structural differences between subtypes.
Main Results:
- Cryo-EM structures revealed how type IV-A effector complexes recognize the protospacer adjacent motif (PAM) and target DNA strand.
- Formation of an R-loop structure was observed, crucial for interference.
- Distinct structural features in type IV-A1 and IV-A3 complexes facilitate the recruitment of the DinG helicase.
Conclusions:
- The study provides a detailed structural understanding of nuclease-independent DNA interference by type IV-A CRISPR-Cas systems.
- The findings highlight differences in DNA interaction and helicase recruitment between type IV-A subtypes.
- This structural foundation can aid in the development of novel CRISPR-Cas-based genome editing tools.
Related Concept Videos
CRISPR and crRNAs
16.8K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
16.8K
CRISPR
49.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
49.7K
Homologous Recombination
50.2K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.2K
RNA Interference
25.9K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
25.9K
Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K

